arrow
返回
C

Chiun Hsu

national taiwan university

56H指数
409论文数
1.9W被引数
收录论文 150
发表时间
Evaluating physicians’ teaching perspectives and demonstration of core competencies in clinical shadowing评估医师在临床观摩中的教学视角及核心能力的展现
err2025-12-29
err0
errOAAI
errChiao-Ling Tsai; Chun-Ta Huang; Chih-Wei Yang; Yen-Lin Chiu; Chia-Ter Chao; Mong-Wei Lin; Chao-Chi Ho; Huey-Ling Chen; Chiun Hsu
err分享
err收藏
err分享
err收藏
LIVER-R study protocol: a global real-world study of durvalumab-based regimens in patients with hepatobiliary cancersLIVER-R研究方案:一项关于 durvalumab为基础方案在肝胆肿瘤患者中的全球真实世界研究
err2025-11-24
err0
errOAAI
errMasafumi Ikeda; Marcus-Alexander Wörns; Mehmet Akce; Chiun Hsu; Niall C. Tebbutt; Andrea Casadei-Gardini; Janvi Sah; Mufiza Farid-Kapadia; Heide A. Stirnadel-Farrant; Michael J. Paskow; Boris Baur; Giovanni Melillo; James Schmidt; Anna Daktera; Jennifer J. Knox
err分享
err收藏
Aristolochic Acid and Alternative Lengthening of Telomeres Mechanisms Underlie Liver Angiosarcoma Pathogenesis马兜铃酸和端粒延长替代机制是肝血管肉瘤发病的基础
err2025-11-01
err0
errOAAI
errChen, Tom Wei-Wu; Hsu, Chiun; Lee, Jen-Chieh; Chang, Koping; Huang, Shih-Chiang; Chu, Hsueh-Ping Catherine; Chen, Chung-Hsin; Tsai, Yu-Chieh; Hsueh, Fu-Jen; Kuo, Chun-Hung; Hsu, Chia-Lang; Cheng, Ann-Lii
err分享
err收藏
CD47-Sirpa blockade enhances antitumor activity against mouse liver cancer by boosting cDC2 functions
err2025-11-01
err0
PREAI
errLow, Guan-Sian; Jian, Cheng-Zhe; Tseng, Yi-Chiao; Ou, Da-Liang; Hsu, Chiun; Lee, Chien-Kuo
err分享
err收藏
Nivolumab plus ipilimumab for potentially resectable hepatocellular carcinoma: long-term efficacy and biomarker explorationNivolumab联合ipilimumab治疗潜在可切除的肝细胞癌:长期疗效与生物标志物探索
err2025-09-17
err0
PREAI
errYih-Jyh Lin; Da-Liang Ou; Yung-Yeh Su; Chia-Lang Hsu; Chin-Fu Hsiao; Bor-Sheng Ko; San-Chi Chen; Hung-Wei Wang; Jing-Houng Wang; Yao-Ming Wu; Yung-Ming Jeng; Wei-Chen Lee; Shu-Cheng Chou; Teng-Wei Chen; Chang-Fang Chiu; null Shiuan Lin; Ching-Hung Hsieh; Chi-Chun Lee; Yen-Shen Shen; Ann-Lii Cheng; Li-Tzong Chen; Chiun Hsu
err分享
err收藏
New targets and new drugs for hepatobiliary cancers肝胆肿瘤的新靶点和新药物
err2025-08-25
err0
PREAI
errStephen L. Chan; Angela Lamarca; Chiun Hsu; Victor Moreno; Landon L. Chan; Bridget P. Keenan
err分享
err收藏
Targeting GPX4 to Overcome Sorafenib Resistance of Human Hepatocellular Carcinoma by Inducing Ferroptosis通过诱导铁死亡靶向GPX4以克服索拉非尼抵抗的人肝细胞癌
err2025-08-05
err0
PREAI
errHan-Hsuan Tang; Chi-Pei Hsu; Pin-Yu Su; Shu-Ping Tsai; Ly Hien Doan; Ching-Ying Chen; Hsin-Chih Chen; Pao-Yuan Wang; Tai-Shan Cheng; Chi-Ying F. Huang; Chun-Li Su
err分享
err收藏
Uncovering Reflections of Preclinical Medical Students from Clinical Shadowing: A Thematic Analysis
err2024-11-02
err1
PREAI
errYang, Chih-Wei; Huang, Chun-Ta; Shieh, Jeng-Yi; Chiu, Yen-Lin; Tsai, Chiao-Ling; Chao, Chia-Ter; Tsai, Yi-Ju; Lin, Mong-Wei; Ho, Chao-Chi; Chen, Shyh-Jye; Hsu, Chiun; Chen, Huey-Ling
err分享
err收藏
Changes in Posttreatment Spleen Volume Associated with Immunotherapy Outcomes for Advanced Hepatocellular Carcinoma晚期肝癌治疗后脾脏体积变化与免疫治疗结局的相关性
err2024-06-01
err1
errOAAI
errChen, Bang-Bin; Liang, Po-Chin; Shih, Tiffany Ting-Fang; Liu, Tsung-Hao; Shen, Ying-Chun; Lu, Li -Chun; Lin, Zhong-Zhe; Hsu, Chiun; Hsu, Chih-Hung; Cheng, Ann-Lii; Shao, Yu-Yun
err分享
err收藏
Nivolumab plus ipilimumab combination therapy in patients with advanced hepatocellular carcinoma previously treated with sorafenib: 5-year results from CheckMate 040Nivolumab联合ipilimumab治疗先前接受索拉非尼治疗的晚期肝细胞癌患者: CheckMate 040的5年结果
err2024-06-01
err5
errOAAI
errMelero, I.; Yau, T.; Kang, Y. -K.; Kim, T. -Y.; Santoro, A.; Sangro, B.; Kudo, M.; Hou, M. -M.; Matilla, A.; Tovoli, F.; Knox, J.; He, A. R.; El-Rayes, B.; Acosta-Rivera, M.; Lim, H. Y.; Soleymani, S.; Yao, J.; Neely, J.; Tschaika, M.; Hsu, C.; El-Khoueiry, A. B.
err分享
err收藏
A potential novel cancer immunotherapy: Agonistic anti-CD40 antibodies一种潜在的新型癌症免疫疗法: 激动性anti-CD40抗体
err2024-03-01
err8
PREAI
errJian, Cheng-Zhe; Lin, Li; Hsu, Chia -Lang; Chen, Yu-Hsin; Hsu, Chiun; Tan, Ching -Ting; Ou, Da-Liang
err分享
err收藏